Companies
Explore our investments
-
University Spinouts investments
-
Established2016In collaboration with UCL Business
-
Total investment> $2bnOver $2bn of follow on funding for portfolio
-
Public offerings4 IPOsFour NASDAQ IPOs since 2018
Featured investments
Universities should not be greedy with technology spin-offs | FT
Dave Grimm, Partner at AlbionVC, chats to John Gapper, Financial Times, on the opportunities that commercialising research presents, on the back of our very successful partnership with UCL.
UK universities take record low spinout stakes: ‘But that’s only half the battle’
David Grimm, Partner AlbionVC discusses university spinout terms and timelines with Sifted
Today, 90% of Russell Group universities have affiliated funds as reported by Sifted
Why We’re Bullish on London University Spinouts
Companies
-
Achilles TherapeuticsBiopharmaceutical company developing precision T cell therapies
-
Apollo Therapeuticsbiopharmaceutical company advancing a robust pipeline of potentially transformative therapeutic programs
-
Axovia TherapeuticsGene therapy company developing disease-transformative medicines for ciliopathies
-
Bloomsbury AIEnabling everyone to easily create their own question-answering system
-
Bloomsbury GTXBiotechnology company developing potentially curative treatments for patients suffering from rare neurological and metabolic diseases
-
Bramble EnergyFuel cell company on a mission to help the world achieve net zero
-
Carbon ReClimate tech startup utilising AI to achieve operational efficiency in energy intensive industries
-
Echopoint MedicalTransforming interventional cardiology with optical-fibre based sensors
-
EpilepsyGTxBiotechnology company developing of cutting-edge gene therapies to treat focal refractory epilepsy
-
EpsilogenImmuno-oncology company targeting cancer with the IgE class of antibodies
-
GaussionRevolutionising batteries through magneto-electrochemistry: MagLiB technology.
-
HazySynthetic data platform
-
HumanloopSoftware development company that helps businesses build and test AI applications based on large language models (LLMs)
-
IntrinsicDeveloping a new type of all silicon non-volatile memory
-
Meira GTXVertically integrated, clinical stage gene therapy company
-
NovalGenImmuno-oncology company developing breakthrough bispecific therapies that can safely harness the immune system to fight cancer
-
Nozzle.aiAI powered platform that unifies large datasets and automatically optimises sales performance for marketplace sellers
-
Odin VisionBuilds a new era of cloud connected endoscopy
-
Orchard TherapeuticsBiotechnology company bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
-
Oriole NetworksUCL spinout using light to train LLMs a hundred times faster with only a fraction of power
-
Panangium TherapeuticsBiologic for retinal disease targeting a novel alternative pathway to VEGF
-
PhasecraftUsing disruptive theory to unlock the power of quantum computing
-
PometrySoftware company simplifying graph analytics for businesses
-
Quell TherapeuticsA clinical stage company transforming lives in immune mediated disease
-
Spur TherapeuticsBiopharmaceutical company focused on the development of liver-directed gene therapies
-
Stanhope AIAI startup leveraging active inference and the free energy principle to build ‘Agentic AI’ for the real world.
-
Third Space LearningEdTech platform connecting tutors in the developing countries to students in developed economies